Please login or register first to view this content.
Endocrine Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
FDA Warns of Cybersecurity Risk With Certain Medtronic Insulin Pumps
USPSTF: Evidence Lacking for Screening Children for Prediabetes, T2D
Automated Insulin Delivery Ups Time in Target Glucose Range in T1D
Most Adult ED Visits Are for Patients With Chronic Conditions
Kerendia Label Updated With CV Outcomes Data From the FIGARO-DKD Study
Vitamin D Supplementation May Aid New-Onset Pediatric T1DM
Omnipod 5 Tubeless Automated Insulin Delivery System Cleared for Younger Kids
FDA: Nitrosamine Impurity Detected in Diabetes Drug Sitagliptin
July 2022 Recap: Drug Pipeline Updates
FDA Approves Oral Testosterone Replacement Therapy Kyzatrex
Daily Insulin Dose Tied to Cancer Risk in Patients With T1DM
Noninferiority of Once-Weekly Insulin Icodec Demonstrated in Two T2D Trials
Sotagliflozin Under Review for Heart Failure Treatment
Long-Acting PTH Prodrug Granted Orphan Drug Status for Hypoparathyroidism
Effect of Keto and Mediterranean Diets on Glucose Control Compared
Nonmedical Interventions May Improve Type 2 Diabetes Outcomes
California Will Produce Its Own Insulin to Bring Down Prices
Abiraterone and Enzalutamide Raise Metabolic, Cardiovascular Adverse Event Risks
